The adventure begins! For those who would like to hear more from me, well here you go! (Find it on your favorite po… https://t.co/Q1s3RMh8Sy
RT @OlinkProteomics: Kim: Each have a cell profile, activating cytokines, and effector cytokines; a total of 15 inflamm skin diseases, 12 c…
RT @OlinkProteomics: Kim: Summarizing: 3 modules, pts w/GoF and in mice, JAK1 is impt for atopic derm.; TYK2 an impt role in Type 3 (IL-12,…
RT @CytokineSociety: @prokuninaolsson @SegunOnabajo visiting the @OlinkProteomics booth #cytokines2022
New post: Proteomics in Proximity: Co-Hosting a New Podcast https://t.co/DKWXVo7W9C
RT @OlinkProteomics: Belkaid (NIAID) Multi-Kingdom Control of Tissue Immunity at #Cytokines2022 Fascinating talk with involvement of S Aure…
RT @OlinkProteomics: Remarkable talk by Dr Yasmine Belkaid (NIAID) Multi-Kingdom Control of Tissue Immunity at #Cytokines2022 How the micro…
RT @OlinkProteomics: Fascinating talk by Dr Lydia Lunch (HMS) at #cytokines2022 on “IL-17, Neuropeptide first, Cytokine second?” She studie…
If you happen to be attending #Cytokines2022 do come by on Friday 23 Sept - worth a look! https://t.co/gI6ANCwxqX
RT @taylorlawley: @StahlbergAnders talking about liquid biopsy and preanalytical sample quality considerations for SiMSen-Seq same workflow…
RT @taylorlawley: @APalotie gave a beautiful talk highlighting critical importance of a data sharing environment to enable actionability of…